Invention Grant
- Patent Title: Method of treating psoriatic arthritis, psoriasis, and chronic obstructive pulmonary disease with a novel 2,5-substituted pyrimidines
-
Application No.: US15354424Application Date: 2016-11-17
-
Publication No.: US10391099B2Publication Date: 2019-08-27
- Inventor: Antonio Nardi , Florian Jakob , Ingo Konetzki , Tobias Craan , Christian Hesslinger
- Applicant: Grünenthal GmbH
- Applicant Address: DE Aachen
- Assignee: GRUENENTHAL GMBH
- Current Assignee: GRUENENTHAL GMBH
- Current Assignee Address: DE Aachen
- Agency: Norris McLaughlin, P.A.
- Priority: EP14002450 20140716
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/506 ; C07D403/04 ; C07D403/14 ; C07D471/04 ; C07D401/14
Abstract:
The invention relates to novel substituted condensed pyrimidine compounds of general formula (I) in which the chemical groupings, substituents and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.
Public/Granted literature
- US20170065603A1 Novel 2,5-substituted pyrimidines Public/Granted day:2017-03-09
Information query
IPC分类:
